s100β, NSE n GFAP in Living Donor Hepatectomy and Delirium

CompletedOBSERVATIONAL
Enrollment

56

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

November 1, 2021

Study Completion Date

December 1, 2021

Conditions
Donor Site ComplicationDeliriumUremic EncephalopathyNeurologic Manifestations
Interventions
PROCEDURE

Living Donor Hepatectomy

On living donor hepatectomy (preoperative), the first following day of surgery, 3rd day, and 7th day, blood will be taken for the measurement of S100β, NSE, and GFAP levels in the postoperative period. The plasma of the blood taken will be separated and stored at -800C. Values will be measured by the ELISA method. During the hospitalization, the delirium status of the patients will be evaluated with the delirium evaluation scale (Delirium Rating Scale-Revised - 98 Turkish version). Functional and cognitive information and other results will be collected at each follow-up point.

Trial Locations (1)

07059

Akdeniz University Medical Faculty Department of Anesthesiology and Reanimation, Antalya

All Listed Sponsors
lead

Akdeniz University

OTHER

NCT04422925 - s100β, NSE n GFAP in Living Donor Hepatectomy and Delirium | Biotech Hunter | Biotech Hunter